Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: A study on the pathophysiology of hepatic encephalopathy

American Journal of Gastroenterology

Volumn 105, Issue 6, 2010, Pages 1374-1381

  Riggio, Oliviero ^a   Mannaioni, Guido ^b   Ridola, Lorenzo ^a   Angeloni, Stefania ^a   Merli, Manuela ^a   Carl, Vincenzo ^b   Salvatori, Filippo Maria ^a   Moroni, Flavio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; INDOLE; OXINDOLE;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; DISEASE SEVERITY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATIC VEIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; ULTRAVIOLET SPECTROPHOTOMETRY;

AGED; AMMONIA; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INDOLES; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PSYCHOMOTOR PERFORMANCE; SPLANCHNIC CIRCULATION;

EID: 77953230272     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.738     Document Type: Article

References (34)

1. Ferenci P, Lockwood A, Mullen K et al. Hepatic encephalopathy\defi nition, nomenclature, diagnosis, and quantifi cation: Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
2. Fraser CL, Arieff AI. Hepatic encephalopathy. N Engl J Med 1985; 313: 865-873
3. Masini A, Efrati C, Merli M et al. Eff ect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patients. Metab Brain Dis 2003; 18: 27-35.
4. Efrati C, Masini A, Merli M et al. Eff ect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution. J Gastroenterol 2000; 95: 3574-3578
5. McClain CJ, Zieve L, Doizaki WM et al. Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy. Gut 1980; 21: 318-323
6. Zieve FJ, Zieve L, Doizaki WM et al. Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther 1974; 191: 10-16
7. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971; 2: 75-80.
8. Baraldi M, Zeneroli ZL. Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. Science 1982; 216: 427-429
9. Jones EA, Shafer DE, Ferenci P et al. The neurobiology of hepatic encephalopathy. Hepatology 1984; 4: 1235-1284
10. Moroni F, Riggio O, Carl à V et al. Hepatic encephalopathy: lack of changes of GABA content in plasma and cerebrospinal fl uid. Hepatology 1987; 7: 816-820
11. Panerai AE, Salerno F, Baldissera F et al. Brain beta-endorphin concentrations in experimental chronic liver disease. Brain Res 1982; 247: 188-190
12. Moroni F, Lombardi G, Moneti G et al. The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 1983; 40: 850-854
13. Monfort P, Munoz MD, Elayadi A et al. Eff ects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis 2002; 17: 237-250
14. Olasmaa M, Rothstein JD, Guidotti A et al. Endogenous benzodiazepine in human and animal hepatic encephalopathy. J Neurochem 1990; 55: 2015-2023 (Pubitemid 120021834)
15. Norenberg MD, Itzhak Y, Bender AS. The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv Exp Med Biol 1997; 420: 95-111.
16. Mullen KD, Szauter KM, Kaminsky-Russ K. " Endogenous " benzodiazepine activity in body fl uids of patients with hepatic encephalopathy. Lancet 1990; 336: 81-83
17. Ono J, Huston DG, Dombro RS et al. Tryptophan and hepatic coma. Gastroenterology 1996; 74: 196-200.
18. Bengtsson F, Bugge M, Johansen KH et al. Brain tryptophan hydroxylation in the portocaval shunted rat: a hypothesis for the regulation of serotonin turnover in vivo. J Neurochem 1991; 56: 1069-1074
19. Moroni F, Carpenedo R, Mannaioni G et al. Studies on the pharmacological properties of oxindole and 5-hydroxyindole: are they involved in hepatic encephalopathy?. In Felipo V, Grisolia S (eds). Advances in Cirrhosis, Hyperammonemia and Hepatic Encephalopathy. Vol 420 Penum Press: New York, 1997, 57-75.
20. Orcutt JA, Prytherch JP, Konicov M et al. Some new compounds exhibiting selective CNS-depressant activities. Part1, preliminary observations. Arch Int Pharmacodyn 1964; 152: 121-131
21. Mannaioni G, Carpenedo R, Pugliese AM et al. Electrophysiological studies on oxindole, a neurodepressant tryptophan metabolite. Br J Pharmacol 1998; 125: 1751-1760
22. Carpenedo R, Mannaioni G, Moroni F. Oxindole, a neurodepressant tryptophan metabolite, accumulates in blood or brain of rats with hepatic failure. J Neurochem 1998; 70: 1998-2003.
23. Moroni F, Carpenedo R, Venturini I et al. Oxindole in pathogenesis of hepatic encephalopathy. Lancet 1998; 351: 9119.
24. Suyama Y, Hirayama C. Serum indole and skatole in patients with various liver diseases. Clin Chim Acta 1988; 176: 203-206
25. Sampietro G, Rossi P, Di Marco P. Use of a laryngeal mask in transjugular intrahepatic portosystemic shunt procedures. J Vasc Interv Radiol 1998; 9: 169.
26. Angeloni S, Merli M, Salvatori F et al. Polytetrafl uorethylene-covered stent-graft for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol 2004; 99: 280-285
27. Pugh RNH, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
28. Malinchoc M, Kamath PS, Gordon FD et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
29. Conn HO, Leevy CM, Vlahcevic ZR et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-583
30. Nicolao F, Efrati C, Masini A et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol 2003; 38: 441-444
31. Amodio P, Wenin H, Del Piccolo F et al. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res 2002; 14: 117-131
32. Manning RT. A nomogram for estimation of pnh3. J Lab Clin Med 1964; 63: 297-298
33. Carpenedo R, Carl à V, Moneti G et al. Identifi cation and measurement of oxindole (2-indolinone) in the mammalian brain and other rat organs. Analyt Biochem 1997; 244: 74-79
34. Uribe M, Berthier JM, Lewis H et al. Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double-blind randomized controlled study. Gastroenterology 1981; 81: 101-106